Alivus Life Sciences Ltd.

The total revenue for the quarter ended June 2024 remained nearly unchanged at Rs. 5886.16 millions.Net profit declined -17.69% to Rs. 1114.83 millions from Rs. 1354.50 millions.Operating Profit reported a sharp decline to 1649.78 millions from 1950.12 millions in the corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202406	202306	% Var	202406	202306	% Var	202403	202303	% Var
Sales	5886.16	5784.50	1.76	5886.16	5784.50	1.76	22832.14	21612.20	5.64
Other Income	54.93	18.51	196.76	54.93	18.51	196.76	120.42	289.57	-58.41
PBIDT	1649.78	1950.12	-15.40	1649.78	1950.12	-15.40	6862.88	6712.50	2.24
Interest	3.53	3.96	-10.86	3.53	3.96	-10.86	15.46	5.47	182.63
PBDT	1646.25	1946.16	-15.41	1646.25	1946.16	-15.41	6847.42	6707.03	2.09
Depreciation	143.87	126.12	14.07	143.87	126.12	14.07	534.52	420.94	26.98
PBT	1502.38	1820.04	-17.45	1502.38	1820.04	-17.45	6312.90	6286.09	0.43
TAX	387.55	465.54	-16.75	387.55	465.54	-16.75	1604.02	1616.48	-0.77
Deferred Tax	12.38	29.55	-58.10	12.38	29.55	-58.10	81.88	110.37	-25.81
PAT	1114.83	1354.50	-17.69	1114.83	1354.50	-17.69	4708.88	4669.61	0.84
Equity	245.05	245.05	0.00	245.05	245.05	0.00	245.05	245.05	0.00
PBIDTM(%)	28.03	33.71	-16.86	28.03	33.71	-16.86	30.06	31.06	-3.22